Market News: Novartis Pharmaceuticals Receives Positive Opinion from the Human Medicines Council on COSENTYX® for the treatment of polymyalgia rheumatica.

Zhitongcaijing · 3d ago
Market News: Novartis Pharmaceuticals Receives Positive Opinion from the Human Medicines Council on COSENTYX® for the treatment of polymyalgia rheumatica.